FREE Virtual Study Fair | 1 - 2 March | REGISTER NOW FREE Virtual Study Fair | 1 - 2 March | REGISTER NOW

Roslin Foundation Studentship - Determining the potential of CpG enrichment as a live attenuated vaccine augmentation strategy for influenza A virus

   College of Medicine and Veterinary Medicine

This project is no longer listed on and may not be available.

Click here to search for PhD studentship opportunities
  Dr E Gaunt, Prof P Digard  No more applications being accepted  Competition Funded PhD Project (Students Worldwide)

About the Project

Influenza A virus (IAV) is a globally distributed pathogen that causes seasonal winter epidemics and frequent pandemics in humans and birds. Each respiratory season, new vaccines need to be formulated, manufactured at scale (typically by growing the virus in chicken eggs) and administered to hundreds of millions of people. Providing effective vaccines in sufficient quantities to protect against influenza is a massive ongoing global challenge.

CpG dinucleotide enrichment of a virus genome is an appealing live attenuated vaccine development strategy. In the IAV genome, CpGs are markedly suppressed (i.e., cytosine immediately followed by guanine occurs rarely [1]). This is because an antiviral protein made by the host, ZAP, binds CpG sites in viral RNA to target it for degradation. We have shown that adding CpGs into the genome of IAV results in ZAP-mediated virus attenuation [2]. We found that infection of mice with a sub-clinical dose CpG-high IAV offers protection from subsequent infection with a lethal dose of IAV, demonstrating the potential of this approach in influenza vaccinology.

The goal of this project is to advance our technology by addressing the following aims:

1. Determine whether CpG enrichment can be applied as an attenuation strategy to multiple IAV strains from a range of species, including avian influenza

2. Optimise parameters for CpG enrichment, including testing CpG enrichment in multiple viral segments

3. Test approaches for making virally encoded CpGs more visible to the host cell by performing experiments to test RNA structure, integrating bioinformatics and SHAPE-MaP approaches in the lab.

In this interdisciplinary project you will learn a range of laboratory methods including cell culture, virus infections, reverse genetics, and SHAPE-MaP. In silico, you will design CpG-enriched viruses. You will regularly present at lab meetings and have the opportunity to present more widely at conferences.

Funding Notes

This 4 year studentship opportunity is open to UK and international students and provides funding to cover enhanced stipend, tuition fees and enhanced consumable and travel costs. Applications including a statement of interest and full CV with names and addresses (including email addresses) of two academic referees, should be emailed to [Email Address Removed].
When applying for the studentship please state clearly the project title/s and the supervisor/s in your covering letter.


1. Gaunt and Digard, WIREs RNA, 2021. Compositional biases in RNA viruses: causes, consequences and applications.
2. Sharp et al., bioRxiv, 2022. CpG enrichment as a live attenuated vaccine development strategy for influenza A virus.

Open days

PhD saved successfully
View saved PhDs